U.S. Health Care REITs Stock News

Cadence Bank was recently added to the Zacks Rank #1 (Strong Buy) list after analysts raised their earnings estimates over the past 60 days. This recognition by Zacks, a widely followed stock ranking platform, highlights increased analyst confidence and potential for heightened investor attention to Cadence Bank. We'll examine how Cadence Bank's inclusion on the Zacks Strong Buy list could influence the company’s investment outlook and analyst narrative. This technology could replace...

American Express recently announced new multi-year partnerships to become the Official Payments Partner of Hard Rock Stadium, the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX, and the Miami Dolphins, expanding exclusive perks and venue access for Card Members across South Florida. This collaboration brings Hard Rock Stadium into the American Express Venue Collection™, offering Card Members exclusive concession offers, presale ticket opportunities, and dedicated lounges, highlighting American...

In recent days, EHang Holdings secured all necessary CAAC certifications for its eVTOL aircraft and received a bullish endorsement from J.P. Morgan, who highlighted the company's strong path toward profitability and industry leadership. This development positions EHang ahead of U.S. peers like Joby Aviation and Archer Aviation, with analysts noting its first-mover advantage and expanding global order backlog. JPMorgan also underscored EHang's leadership in the regulatory approval race,...

On August 21, 2025, OUTFRONT Media appointed Nick Brien as permanent CEO and named Michael Barrett and Nicolle Pangis to its Board of Directors, while also announcing a major partnership with the Bay Area Host Committee for Super Bowl LX and the FIFA World Cup. The addition of high-profile experts in advertising technology and the exclusive tie-in with two of the world’s biggest sporting events underscores OUTFRONT’s push to modernize and expand its digital out-of-home offering. We'll...

Recently, Zurn Elkay Water Solutions received a Strong Buy (Zacks Rank #1) rating, with analysts raising their current-year earnings estimate by 6.7% over the past 60 days. This positive analyst sentiment and upward revisions in earnings estimates highlight strengthening expectations for the company's financial outlook and operational performance. To assess the implications of these upward earnings estimate revisions, we'll examine how this development could impact Zurn Elkay's broader...

Ulta Beauty and Target announced in August 2025 that they will not renew their shop-in-shop partnership, concluding the collaboration by August 2026 with Ulta maintaining in-store presence until that date. Ulta Beauty also appointed Martin Brok and Stephenie Landry to its board, emphasizing deep retail, consumer technology expertise, and board diversity with women comprising 67% of directors. We'll examine how Ulta’s addition of experienced board members could influence its investment...

Earlier this week, Merit Medical Systems announced the successful enrollment of the first patient in the WRAP North America registry, a study evaluating the real-world outcomes of the WRAPSODY CIE device for restoring vascular access in hemodialysis patients across the US and Canada. This milestone adds to Merit Medical’s expanding clinical evidence base and brings new insights into the use of WRAPSODY CIE following recent regulatory approvals in North America and Europe. We’ll explore how...

Stryker Corporation recently reported robust second-quarter 2025 results, citing strong growth in its orthopaedics segment and increasing adoption of the Mako robotic platform. Management also raised full-year sales and earnings guidance, attributing the momentum to operational synergies from recent acquisitions amid ongoing sector challenges. We'll explore how the raised outlook and Mako platform adoption feed into Stryker's long-term growth prospects and investment narrative. This...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

If you’ve been watching BlackRock (BLK) lately, you might have noticed the stock catching a bit more attention with its latest move. The shares perked up about 2% in the most recent session, a jump that has investors once again reconsidering what’s factored into BlackRock’s valuation. There was no headline-grabbing event driving this uptick, which makes the move itself stand out. This is especially true for those trying to figure out whether this is just routine market noise or a subtle...

Coastal Financial (CCB) is back in the spotlight after disappointing the market with its most recent quarterly results. The company missed expectations on both revenues and net interest income. For investors, earnings misses like this can feel like a warning sign or, sometimes, an early clue to a bigger story unfolding beneath the surface. Coastal is already known for making moves in the digital banking and community space, and leadership has recently doubled down by bringing new executive...

Investors may wish to note that the Chief Medical Officer of Voyager Therapeutics, Inc. , Toby Ferguson, recently...

Earlier this week, The Hanover Insurance Group announced it had priced a US$500 million senior unsecured notes offering at 5.50%, due September 1, 2035, aiming to close the transaction around August 21, 2025. This move allows Hanover to refinance its higher-interest debt maturing in 2025 and 2026, which could improve its interest expense profile and enhance financial flexibility. We'll examine how Hanover's refinancing of higher-rate notes with a new debt issuance could shape its...

Xylem Inc.'s Board of Directors declared a third quarter dividend of US$0.40 per share, payable on September 25, 2025, to shareholders of record as of August 28, 2025. This dividend announcement comes on the heels of upward analyst revisions and strong earnings growth, highlighting investor confidence in Xylem’s financial outlook. We'll explore how the latest dividend declaration and upgraded earnings estimates may impact Xylem's long-term investment story. Explore 23 top quantum computing...

Fortinet (FTNT) shares have jumped almost 3% today, catching many investors’ attention and sparking a flurry of questions about what exactly is driving the action. While there was no major news or headline event specific to the company, sometimes price moves like this can be an early signal. Whether it is a shift in investor sentiment or simply market volatility, days like these often prompt a closer look at what the market is seeing in the stock. If we zoom out, Fortinet has delivered a...

Earlier this week, Twist Bioscience announced the launch of its customizable Oncology DNA Comprehensive Genomic Profiling Panel, designed to assist researchers, clinical labs, and biopharma partners in uncovering diverse genomic alterations across a wide spectrum of tumor types for oncology research. By integrating up-to-date biomarkers covering 562 genes and collaborating with analytics firms, Twist is aiming to deliver a full workflow solution that could increase its appeal to a broader...

EPAM Systems recently raised the lower end of its 2025 organic constant currency growth forecast and increased full-year earnings guidance following strong second-quarter results. This positive outlook is attributed to strong client demand for generative AI solutions and the company's ability to withstand end market pressures affecting some industry peers. We'll assess how EPAM's upgraded AI-driven guidance shapes the company's longer-term investment narrative and growth expectations. This...

Cathay General Bancorp recently announced that its Board of Directors declared a cash dividend of US$0.34 per common share, payable on September 8, 2025, to shareholders of record as of August 28, 2025. While the dividend announcement highlights Cathay General Bancorp’s steady track record of distributions, broader sector momentum from Federal Reserve policy commentary has been a more influential force in recent market activity. We’ll explore how renewed confidence in the regional banking...

Zoetis (NYSE:ZTS) is back in the spotlight after raising almost $1.85 billion in fresh capital through two new fixed-income offerings, with several global banks brought onboard as co-lead underwriters. For investors watching the animal health leader, this round of senior, unsecured notes is more than a routine capital markets event. It is a clear signal that Zoetis is actively shaping its balance sheet, which raises questions about how the company intends to deploy these funds and whether the...

Earlier this week, Zacks Investment Research highlighted ITT as a top growth stock due to its strong earnings outlook and positive Growth Score, with expectations for its EPS to grow 10.6% this year, outpacing the industry average. A key insight is that recent upward revisions to ITT’s earnings estimates reinforce market confidence in its near-term performance potential. We'll examine how analyst optimism about ITT's earnings growth and favorable estimates may influence the company's overall...

Amneal Pharmaceuticals recently raised its full-year 2025 guidance following strong quarterly performance and announced progress on two Denosumab biosimilar candidates currently under FDA review, with regulatory decisions expected later in 2025. In addition to these operational updates, Amneal strengthened its financial position through debt refinancing and expects to generate net revenue between US$3.0 billion and US$3.1 billion with adjusted EPS in the range of US$0.70 to US$0.75 this...

Expro Group Holdings has just completed the world's first fully remote five-plug cementing operation in Saudi Arabia, a breakthrough that is drawing serious investor attention. This achievement is more than a technical milestone and signals Expro’s growing presence in one of the energy sector’s most demanding markets. By leveraging its proprietary Generation-X Remote Plug Launcher and SkyHook cement-line device, Expro has set a new standard for personnel safety and operational efficiency. The...

Globalstar (GSAT) has been turning heads after clinching a series of new government contracts and unveiling strategic partnerships, including a notable collaboration with the U.S. Army. The company is leveraging its Low Earth Orbit satellite constellation and advanced networking technologies to supply essential communications solutions for defense and government clients. This activity is not just about headlines, as management confirmed at least $60 million in new contract revenue over the...

Veracyte, a global diagnostics company specializing in advanced genomic tests for cancer, recently experienced upward revisions in earnings estimates alongside strong earnings momentum and a favorable Zacks Rank #3 rating. This renewed analyst optimism has positioned Veracyte as a prominent momentum stock, reflecting heightened confidence in its growth outlook within the diagnostics sector. We will assess how the positive shift in analyst earnings estimates could influence Veracyte’s broader...